Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Influence of age on the prognostic value of mid-regional pro-adrenomedullin in the general population.

Brouwers FP, de Boer RA, van der Harst P, Struck J, de Jong PE, de Zeeuw D, Gans RO, Gansevoort RT, Hillege HL, van Gilst WH, Bakker SJ.

Heart. 2012 Sep;98(18):1348-53. doi: 10.1136/heartjnl-2012-302390.

PMID:
22821276
2.

Midregional proadrenomedullin for prediction of cardiovascular events in coronary artery disease: results from the AtheroGene study.

Wild PS, Schnabel RB, Lubos E, Zeller T, Sinning CR, Keller T, Tzikas S, Lackner KJ, Peetz D, Rupprecht HJ, Bickel C, Morgenthaler NG, Papassotiriou J, Tiret L, Münzel T, Blankenberg S.

Clin Chem. 2012 Jan;58(1):226-36. doi: 10.1373/clinchem.2010.157842.

3.

Mid-region pro-adrenomedullin adds predictive value to clinical predictors and Framingham risk score for long-term mortality in stable outpatients with heart failure.

Xue Y, Taub P, Iqbal N, Fard A, Clopton P, Maisel A.

Eur J Heart Fail. 2013 Dec;15(12):1343-9. doi: 10.1093/eurjhf/hft116.

4.

Associations of mid-regional pro-adrenomedullin levels to cardiovascular and metabolic abnormalities, and mortality in an elderly population from the community.

Eggers KM, Venge P, Lindahl B, Lind L.

Int J Cardiol. 2013 Oct 9;168(4):3537-42. doi: 10.1016/j.ijcard.2013.05.005.

PMID:
23722054
5.

Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study.

Christ-Crain M, Morgenthaler NG, Struck J, Harbarth S, Bergmann A, Müller B.

Crit Care. 2005;9(6):R816-24.

6.

Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.

Khan SQ, O'Brien RJ, Struck J, Quinn P, Morgenthaler N, Squire I, Davies J, Bergmann A, Ng LL.

J Am Coll Cardiol. 2007 Apr 10;49(14):1525-32.

7.

MR-proANP and MR-proADM for risk stratification of patients with acute chest pain.

Tzikas S, Keller T, Ojeda FM, Zeller T, Wild PS, Lubos E, Kunde J, Baldus S, Bickel C, Lackner KJ, Münzel TF, Blankenberg S.

Heart. 2013 Mar;99(6):388-95. doi: 10.1136/heartjnl-2012-302956.

PMID:
23213173
8.

Comparison of midregional pro-A-type natriuretic peptide and the N-terminal pro-B-type natriuretic peptide for predicting mortality and cardiovascular events.

van Hateren KJ, Alkhalaf A, Kleefstra N, Groenier KH, de Jong PE, de Zeeuw D, Gans RO, Struck J, Bilo HJ, Gansevoort RT, Bakker SJ.

Clin Chem. 2012 Jan;58(1):293-7. doi: 10.1373/clinchem.2011.166348.

9.

Mid-regional pro-adrenomedullin in acute heart failure: a better biomarker or just another biomarker?

Potocki M, Ziller R, Mueller C.

Curr Heart Fail Rep. 2012 Sep;9(3):244-51. doi: 10.1007/s11897-012-0096-6. Review.

PMID:
22733501
10.

Association of MR-proadrenomedullin with cardiovascular risk factors and subclinical cardiovascular disease.

Neumann JT, Tzikas S, Funke-Kaiser A, Wilde S, Appelbaum S, Keller T, Ojeda-Echevarria F, Zeller T, Zwiener I, Sinning CR, Jagodzinski A, Schnabel RB, Lackner KJ, Münzel T, Blankenberg S, Wild PS, Sydow K.

Atherosclerosis. 2013 Jun;228(2):451-9. doi: 10.1016/j.atherosclerosis.2013.03.006.

PMID:
23562132
11.

Multiple marker approach to risk stratification in patients with stable coronary artery disease.

Schnabel RB, Schulz A, Messow CM, Lubos E, Wild PS, Zeller T, Sinning CR, Rupprecht HJ, Bickel C, Peetz D, Cambien F, Kempf T, Wollert KC, Benjamin EJ, Lackner KJ, Münzel TF, Tiret L, Vasan RS, Blankenberg S.

Eur Heart J. 2010 Dec;31(24):3024-31. doi: 10.1093/eurheartj/ehq322.

PMID:
20852293
12.

The association of mid-regional pro-adrenomedullin and mid-regional pro-atrial natriuretic peptide with mortality in an incident dialysis cohort.

Gouya G, Sturm G, Lamina C, Zitt E, Freistätter O, Struck J, Wolzt M, Knoll F, Lins F, Lhotta K, Neyer U, Kronenberg F.

PLoS One. 2011 Mar 7;6(3):e17803. doi: 10.1371/journal.pone.0017803.

13.

The fibrosis marker galectin-3 and outcome in the general population.

de Boer RA, van Veldhuisen DJ, Gansevoort RT, Muller Kobold AC, van Gilst WH, Hillege HL, Bakker SJ, van der Harst P.

J Intern Med. 2012 Jul;272(1):55-64. doi: 10.1111/j.1365-2796.2011.02476.x.

14.

Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea.

Shah RV, Truong QA, Gaggin HK, Pfannkuche J, Hartmann O, Januzzi JL Jr.

Eur Heart J. 2012 Sep;33(17):2197-205. doi: 10.1093/eurheartj/ehs136.

15.

Mid-regional pro-adrenomedullin in the early evaluation of acute chest pain patients.

Haaf P, Twerenbold R, Reichlin T, Faoro J, Reiter M, Meune C, Steuer S, Bassetti S, Ziller R, Balmelli C, Campodarve I, Zellweger C, Kilchenmann A, Irfan A, Papassotiriou J, Drexler B, Mueller C.

Int J Cardiol. 2013 Sep 30;168(2):1048-55. doi: 10.1016/j.ijcard.2012.10.025.

PMID:
23199555
16.

Predictive value of midregional pro-adrenomedullin compared to natriuretic peptides for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort.

Funke-Kaiser A, Havulinna AS, Zeller T, Appelbaum S, Jousilahti P, Vartiainen E, Blankenberg S, Sydow K, Salomaa V.

Ann Med. 2014 May;46(3):155-62. doi: 10.3109/07853890.2013.874662.

PMID:
24506434
17.

Midregional pro-adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study.

Potocki M, Breidthardt T, Reichlin T, Morgenthaler NG, Bergmann A, Noveanu M, Schaub N, Uthoff H, Freidank H, Buser L, Bingisser R, Christ M, Mebazaa A, Mueller C.

Crit Care. 2009;13(4):R122. doi: 10.1186/cc7975.

18.
19.

Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.

Maisel A, Mueller C, Nowak RM, Peacock WF, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M, Clopton P, Filippatos GS, Di Somma S, Anand I, Ng LL, Daniels LB, Neath SX, Christenson R, Potocki M, McCord J, Hartmann O, Morgenthaler NG, Anker SD.

J Am Coll Cardiol. 2011 Aug 30;58(10):1057-67. doi: 10.1016/j.jacc.2011.06.006.

20.

Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay.

Morgenthaler NG, Struck J, Alonso C, Bergmann A.

Clin Chem. 2005 Oct;51(10):1823-9.

Supplemental Content

Support Center